Most of what we publish here is about separating real evidence from marketing hype. L-theanine is a good example of both a strong evidence base and an honest gap in how we currently sell it: it's already in two products in our range, but not yet as a standalone, individually-dosed capsule you can buy on its own. Here's what the evidence actually supports, and where dose transparency still needs work.
What the evidence actually shows
L-theanine is an amino acid found almost exclusively in tea leaves (Camellia sinensis), which is why "a cup of green tea to calm down" shows up so often in relaxation folklore. The clinical evidence is narrower and more specific than that folklore suggests — and in some places, more interesting.
A 2026 systematic review and meta-analysis pooled 31 randomized controlled trials (1,168 participants) on L-theanine's cognitive and affective effects.1 The findings were genuinely solid by supplement standards: a single 200mg dose, taken 30–60 minutes before cognitive testing, produced a meaningful improvement in choice reaction time (effect size 0.51) — a real, measurable attention effect. Stress reduction was more modest (effect size 0.31) and the studies behind it carried more risk of bias. Anxiety results were inconsistent across trials. A depression-symptom finding (effect size 0.69) was promising but needs confirmation in clinical populations, not just healthy adults. No serious adverse events were reported anywhere in the pooled data.
That's a real, multi-trial evidence base for a specific dose and specific outcome — exactly the bar we use to decide what earns a place in the range. But "real" and "large" aren't the same thing, and the inconsistency across outcomes (strong on attention, modest on stress, mixed on anxiety) is itself informative about what this ingredient actually does.
It's also worth being honest about the limits of a pooled analysis like this one. Thirty-one trials sounds like a lot, but the individual studies varied in dose, timing, testing method, and how "stress" or "anxiety" was measured — some used validated psychometric scales, others relied on single self-report items or salivary cortisol. That heterogeneity is exactly why the review's authors flagged higher risk of bias on the stress and anxiety outcomes specifically, while the attention finding held up better across more consistently designed trials. When we say the evidence is "modest," this is the kind of detail we mean: a real signal, in a body of research that isn't yet uniform enough to call it settled.
The mechanism, and why the caffeine combination is a different story
Part of why the anxiety and stress data stays inconsistent is that L-theanine's mechanism doesn't map cleanly onto a single symptom. It's structurally similar to glutamate and is thought to modestly increase brain GABA activity while damping excitatory glutamate signaling, and EEG studies consistently show it increases alpha-wave activity — a brain-wave pattern linked to relaxed alertness rather than sedation. That's a real, replicated electrophysiological effect. It just isn't the same thing as "reduces anxiety," which is a much harder clinical outcome to move, and the gap between the two is exactly where a lot of L-theanine marketing overreaches.
Where the newest evidence gets more interesting is L-theanine paired with caffeine, rather than taken alone. A 2025 double-blind, placebo-controlled crossover trial in the British Journal of Nutrition tested 200mg L-theanine plus 160mg caffeine against a starch placebo in 37 healthy adults who had been kept awake overnight — a reasonable stand-in for shift work or exam-week sleep deprivation.2 On a traffic-hazard attention task, the combination measurably improved both accuracy and reaction time.
EEG recordings backed the behavioral result up: the P3b brain-wave component tied to attention and decision-making was larger and appeared faster after the active dose, consistent with the caffeine sharpening alertness while L-theanine's alpha-wave effect kept that alertness from tipping into jitteriness. This lines up with a pattern seen in earlier caffeine-plus-theanine cognition research: the pairing tends to outperform either ingredient taken alone on attention-switching tasks. It's a genuinely useful synergy — but it's a caffeine story as much as a theanine story, which is a different claim than "L-theanine alone reliably calms you down," the one most often made in marketing copy.
None of this changes the safety picture, which is genuinely reassuring: across the pooled meta-analysis and the newer combination trial, no serious adverse events were reported at these doses, and L-theanine has long-standing GRAS (Generally Recognized As Safe) status in the US at typical supplemental amounts. The open questions here are about how strong and how specific the benefits are — not about whether the ingredient is safe to take.
| Protocol | Dose tested | What the trial data shows |
|---|---|---|
| Standalone L-theanine, attention | 200mg, single dose | Meaningful improvement in choice reaction time (effect size 0.51) |
| Standalone L-theanine, stress/anxiety | 200mg, single dose | Modest stress effect (0.31); anxiety results inconsistent across trials |
| Standalone L-theanine, depression symptoms | Varied across pooled trials | Promising signal (0.69) but unconfirmed in clinical, non-healthy populations |
| L-theanine + caffeine, sleep-deprived attention | 200mg L-theanine + 160mg caffeine | ~40ms faster reaction time, higher accuracy, larger/faster P3b EEG response vs placebo |
A real, replicated brain-wave effect is not the same claim as "reduces anxiety" — and that gap is where a lot of L-theanine marketing overreaches.
Where this sits in the range today
L-theanine is already in two Proco products — Cognitive Support and Sleep Support — but in both cases it's bundled inside that product's ingredient blend without an individually disclosed dose, so we can't tell you whether you're getting the 200mg dose the trials above tested or a smaller amount. That's not the standard we hold everything else in the range to. Sleep Formula already discloses an exact per-serving dose for every ingredient it contains; getting Cognitive Support and Sleep Support to the same standard — L-theanine included, alongside GABA and 5-HTP — is in progress.
Once an ingredient sits inside an undisclosed blend, you can't tell whether you're getting the dose the trials actually tested or a token amount added mainly for the label. L-theanine clearing the evidence bar is precisely why it deserves an honest, individually disclosed dose rather than staying folded into a blend total.
This is a familiar shape for us. When a product doesn't meet our standard, the reason is almost never "the ingredient doesn't work" — it's usually a dosing, sourcing, or transparency problem sitting on top of an ingredient that's actually fine. L-theanine is an unusually clean example, because the clinical case is stronger than most of what makes it onto shelves labeled "focus" or "calm" — which is exactly why we're fixing the dose-disclosure gap rather than leaving it as is.
Bottom line
L-theanine's evidence is solid and specific: a well-supported attention effect at 200mg, a genuinely useful pairing with caffeine, and more modest, less consistent results on stress and anxiety alone. It's already in Cognitive Support and Sleep Support — getting the exact per-serving dose onto both labels, alongside GABA and 5-HTP, is next.
This article is for informational purposes only and has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Speak with a healthcare provider before starting any new supplement, especially if you take medication or have an existing health condition.
References
- Cognitive and affective effects of L-theanine: a systematic review and meta-analysis of 31 randomized trials. Molecular Psychiatry, 2026. nature.com
- High-dose L-theanine-caffeine combination improves neurobehavioural and neurophysiological measures of selective attention in acutely sleep-deprived young adults: a double-blind, placebo-controlled crossover study. British Journal of Nutrition, 2025. pmc.ncbi.nlm.nih.gov
Related reading: Why We Don't Sell "Brain Blends" (And What Actually Clears Our Bar).
Want to know the moment full dose disclosure lands? Join the list — no spam, just the range and the evidence behind it.